Pharmaceutical Benefits Under State Medical Assistance Programs

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Introduction.
2. Section 2: Overview of the Medicaid program, details about Medicaid managed care enrollment, including a breakdown by plan type and enrollment by plan type and a synopsis of 1915(b) waivers and 1115 demonstrations.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
5. Section 5: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts.
6. Section 6: Profiles of State pharmaceutical assistance programs. 2007 marked the last year that this compilation was published.

Download the Report.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Introduction.
2. Section 2: Overview of the Medicaid program, details about Medicaid managed care enrollment, including a breakdown by plan type and enrollment by plan type and a synopsis of 1915(b) waivers and 1115 demonstrations.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
5. Section 5: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).
6. Section 6: Profiles of State pharmaceutical assistance programs.

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Estimates of Medicaid expenditures and recipients for FY 2003 to FY 2005 by State.
2. Section 2: Overview of the Medicaid program, details about Medicaid managed care enrollment, including a breakdown by plan type and enrollment by plan type and a synopsis of 1915(b) waivers and 1115 demonstrations.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
5. Section 5: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).
6. Section 6: Profiles of the “expanded” drug programs in States that are providing pharmaceutical coverage or discounts to the elderly and/or disabled persons.

Download Research.

Author: The National Pharmaceutical Council

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

• Section 1: Reports on the Medicare Modernization Act provisions, the dual eligibles it will affect, and the overall impact on the States.
• Section 2: Overview of the Medicaid program, details about Medicaid managed care enrollment, including a breakdown by plan type and enrollment by plan type and a synopsis of 1915(b) waivers and 1115 demonstrations.
• Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
• Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
• Section 5: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).
• Section 6: Profiles of the “expanded” drug programs in States that are providing pharmaceutical coverage or discounts to the elderly and/or disabled persons. 

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Reports on a methodology for identification of Medicaid chronic illness populations for case and disease management programs.
2. Section 2: Overview of the Medicaid program, details about Medicaid managed care enrollment, including a breakdown by plan type and enrollment by plan type and a synopsis of 1915(b) waivers and 1115 demonstrations.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
5. Section 5: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).
6. Section 6: Profiles of the “expanded” drug programs in states that are providing pharmaceutical coverage or discounts to the elderly and/or disabled persons. 

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Reports on the prevalence of asthma, diabetes, and congestive heart failure (CHF) in 15 states using Medicaid Statistical Information System (MSIS) data, including the examination of demographic and comorbidity data.
2. Section 2: Details about Medicaid Managed Care enrollment, including a breakdown by plan type and enrollment by plan type.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC annual survey of state program administrators.
5. Section 5: Profiles of programs in States that are providing expanded pharmaceutical coverage or discounts for the elderly.
6. Section 6: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Reports on the trends in Medicaid expenditures over the last decade, highlighting differences between Medicaid and national spending.
2. Section 2: Details about Medicaid Managed Care enrollment, including a breakdown by plan type and enrollment by plan type.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC survey of state program administrators.
5. Section 5: Profiles of the 20 states that are providing expanded pharmaceutical coverage for the elderly, as of December 31, 2000.
6. Section 6: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Reports on disease management activities in the Medicaid market.
2. Section 2: Details about Medicaid Managed Care enrollment, including a breakdown by plan type and enrollment by plan type.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC survey of state program administrators and Medicaid statistics from the Health Care Financing Administration.
5. Section 5: Profiles of states that are providing expanded drug coverage for the elderly.
6. Section 6: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Reports on disease management activities in the Medicaid market.
2. Section 2: Details about Medicaid Managed Care enrollment, including a breakdown by plan type and enrollment by plan type.
3. Section 3: Socio-demographic statistics and a description of the Medicaid-certified facilities in each state.
4. Section 4: Medicaid pharmacy program characteristics, drawn largely from the NPC survey of state program administrators and Medicaid statistics from the Health Care Financing Administration.
5. Section 5: Profiles of states that are providing expanded drug coverage for the elderly.
6. Section 6: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Socio-demographic statistics and a description of the healthcare delivery system in each state.
2. Section 2: Medicaid pharmacy program characteristics, drawn largely from the NPC survey of state program administrators and Medicaid statistics from the Health Care Financing Administration.
3. Section 3: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act) presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. The information in this book is summarized in the following sections:

1. Section 1: Changes in the Medicaid program and the potential effect of those changes on case delivery.
2. Section 2: Socio-demographic statistics and a description of the healthcare delivery system in each state.
3. Section 3: Compilation of pharmacy program characteristics, drawn largely from the NPC survey and HCFA statistics.
4. Section 4: Detailed profile of the states’ Medicaid pharmacy program (including medical assistance benefits and eligibles, drug payments and recipients, benefit design, pharmacy payment and patient cost sharing, use of managed care and state contacts).

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. This edition offers analysis on Medicaid waivers, block grants, any willing provider legislation and medical savings accounts.

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs. Enhancements to previous years include sections on the Medicaid program and all state health reform activities, as well as state-by-state analyses of payment and coverage trends.

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. The data collection effort covers all states with Medicaid programs.

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program 
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program 
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act) presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Amount expended for drugs per recipient category
3. Characteristics of the state drug program
4. Restrictions or limitations on drugs
5. Medicaid or public health officials
6. Pharmacy and medical consultants to the state program
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of the Medicaid program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Medicaid or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act) presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided. This compilation provides the following information for each state:

1. Recipient groups eligible for benefits
2. Brief description of state medical assistance program
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Public assistance or public health officials
7. Pharmacy and medical consultants to the state program
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This edition of the Pharmaceutical Benefits Under State Medical Assistance Programs includes information that reflects the changes resulting from implementation of Title XIX of Public Law 89-97 (enacted as the Social Security Act of 1965) by some 53 jurisdictions as well as changes made in state programs operating under earlier Social Security titles.

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This edition of the Pharmaceutical Benefits Under State Medical Assistance Programs includes information that reflects the changes resulting from implementation of Title XIX of Public Law 89-97 (enacted as the Social Security Act of 1965) by some 52 jurisdictions as well as changes made in state programs operating under earlier Social Security titles. 

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This edition of the Pharmaceutical Benefits Under State Medical Assistance Programs includes information that reflects the changes resulting from implementation of Title XIX of Public Law 89-97 (enacted as the Social Security Act of 1965) by some 52 jurisdictions as well as changes made in state programs operating under earlier Social Security titles.

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This edition of the Pharmaceutical Benefits Under State Medical Assistance Programs includes information that reflects the changes resulting from implementation of Title XIX of Public Law 89-97 (enacted as the Social Security Act of 1965) by some 52 jurisdictions as well as changes made in state programs operating under earlier Social Security titles.

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This edition of the Pharmaceutical Benefits Under State Medical Assistance Programs includes information that reflects the changes resulting from implementation of Title XIX of Public Law 89-97 by some 44 jurisdictions as well as changes made in state programs operating under earlier Social Security titles. This report includes state information regarding:

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This 1968 report provides a general overview of the characteristics of State Medical Assistance (Title XIX, or Medicaid) and State Public Assistance Medical Care (prior Titles of the Social Security Act) programs along with detailed information on the pharmaceutical benefits provided. This report contains the following information for each state: 

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance or Public Assistance Medical Care Programs
3. Magnitude of the state drug program
4. Existing restrictions or limitations on drugs
5. Data, when available, on caseload or persons eligible to receive health care benefits, including pharmaceutical benefits
6. Welfare or public health officials
7. Pharmacy and medical consultants to welfare or public health departments
8. Pharmacy and medical advisory committees
9. State medical and pharmaceutical association executives

Download Research.

This 1967 report provides a general overview of the characteristics of State Medical Assistance (Title XIX, or Medicaid) and State Public Assistance Medical Care (prior Titles of the Social Security Act) programs along with detailed information on the pharmaceutical benefits provided. Information in this report includes:

1. Recipient groups eligible for benefits
2. Brief descriptions of State Medical Assistance and State Public Assistance Medical Care Programs
3. Magnitude of the state welfare drug program
4. Existing restrictions or limitations on drugs
5. Welfare officials concerned with drug programs
6. Pharmacy and medical consultants concerned with drug programs
7. Pharmacy and medical advisory committees
8. State medical and pharmaceutical association executives programs

Download Research.

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, titled “Data on State Welfare Drug Programs,” provides a state-by-state review of welfare medical care programs. At the time, medical services provided under state welfare programs included inpatient hospital care, nursing home care, physicians’ and other practitioners’ services, dental care, and prescription drugs, although states differed widely in terms of which programs and services they provided. This compilation includes:

1. Brief descriptions of state welfare programs
2. Magnitude of state welfare drug programs
3. Existing restrictions or limitations on drugs
4. Welfare officials concerned with drug programs
5. Pharmacy and medical consultants concerned with drug programs
6. Pharmacy and medical advisory committees

Download Research.

This second edition of the Pharmaceutical Benefits Under State Medical Assistance Programs series, titled “Data on State Welfare Drug Programs,” provides a state-by-state review of welfare medical care programs. At the time, medical services provided under state welfare programs included inpatient hospital care, nursing home care, physicians’ and other practitioners’ services, dental care, and prescription drugs, although states differed widely in terms of which programs and services they provided. This compilation includes:

• Brief descriptions of state welfare programs
• Magnitude of state welfare drug programs
• Existing restrictions or limitations on drugs
• Welfare officials concerned with drug programs
• Pharmacy and medical consultants concerned with drug programs
• Pharmacy and medical advisory committees

Download Research.

This first edition of the Pharmaceutical Benefits Under State Medical Assistance Programs series, titled “State Welfare Programs 1963,” takes a closer look at the ways states provided medical care for recipients of public assistance, as well as the costs associated with that care. At the time, there were two principal mechanisms: States made direct cash payments or provided a public assistance allowance to welfare recipients, or states provided medical assistance through vendors, such as doctors or dentists, and made the payments directly to those health care providers. Some states also utilized welfare prescription programs to provide medicines to public assistance recipients. The National Pharmaceutical Council’s early interest in state prescription programs stemmed from concern over whether physicians would be able to prescribe the brand drugs they considered to be in the best interests of their welfare patients, whether compulsory generic prescribing regulations were adopted by states, or whether restrictive formularies were being used.

Download Research.